Aug 30, 2026•1 min read
FDA Approves ANDA078671 for NABUMETONE Oral Tablets
FDA granted approval for ANDA078671 covering prescription NABUMETONE tablets (500 mg and 750 mg) from sponsor Invagen Pharms, manufactured by Exelan Pharmaceuticals and Cipla USA.